• About
  • Subscribe
  • Advertise
  • Contact
Sunday, March 8, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Red light therapy device to feature at Myopia Progression in Children Conference 2023

by rhiannon bowman
April 12, 2023
in Local, Myopia, News, Therapies
Reading Time: 3 mins read
A A
Myopia child glasses kid children International Myopia Institute

Optometry Australia has awarded a maximum of 6 CPD hours for the event.

Share on FacebookShare on Twitter

Eyerising International will have its red light therapy device on display at the 2023 Myopia Progression in Children Conference (MPIC), featuring alongside many other new therapeutic interventions at the all-day event taking place in Sydney on 10 June.

MPIC strives to update attendees on the wide range of innovations for the intervention of myopia progression in children available in Australia.

Dr Loren Rose.

In addition to HOYA’s MiYOSMART spectacle lens, and the release of the Stellest lens by EssilorLuxottica late last year, ZEISS will soon release a new lens design aimed at retarding the elongation of the eye with a different peripheral defocus profile.

Explanation and discussion of the different lens designs and research results will be available for review at MPIC.

Event organiser, NSW ophthalmologist Dr Loren Rose, said a comprehensive review of myopia management in Australia will be presented and discussed.

“TGA-approved atropine 0.01% (Eikance) is becoming common practice, as are the slightly higher atropine concentrations available from compound pharmacies, with recent publications demonstrating efficacy to be dose-responsive. A stepwise approach will be discussed to ensure safety and efficacy are achieved for all our patients,” she said.

Another innovation gaining attention is red light therapy.

“The use of red light therapy to control axial growth, refraction and choroidal thickness has been published locally and abroad with dramatic results,” Rose said.

“Adaptation of a red light therapy device initially used for amblyopia treatment overseas is now available for myopic children to be prescribed for two intervals of three minutes daily. The publications demonstrate a substantially reduced axial length progression rate. With more studies on the way, Eyerising International will have its red light therapy device present for discussion and use at MPIC 2023.”

The use of axial length and machines to measure it will also be available on the day to add to the comprehensive review of myopia management in children.

Difficult cases will be discussed by an extended panel. Joining Dr Loren Rose, Dr Trent Sandercoe, and Dr Shanel Sharma, will be two new members, Ms Mariella Coluccio and Ms Homma Ebrahimi, to troubleshoot and provide tips on the day.

Optometry Australia has awarded a maximum of 6 CPD hours for the event.

Click here to register.

More reading

Change to Eikance PI recognises therapeutically-endorsed optometrists in myopia management
Rodenstock MyCon myopia control lens launches in Australia
Aussies report red light therapy shortens axial length in myopia

Related Posts

IOP is important but does not tell the full story of a patient's glaucoma. Image: Maria Sbytova/stock.adobe.com.

Solving the complex puzzle of glaucoma

by Dr Justin Sherwin
March 6, 2026

Early intervention is just one of many jigsaw pieces to ponder for eyecare professionals approaching glaucoma, says Australian Society of...

Researchers found that turtles can detect unexpected visual stimuli regardless of where those stimuli fall on the retina. Image: A. Martin UWphoto/stock.adobe.com

Research involving turtles challenges timeline of visual cortex evolution

by Staff Writer
March 6, 2026

Research into turtle brains is reshaping understanding of how visual systems evolved, with scientists reporting that position-invariant visual processing –...

Research has shown a link between sleep issues and dry eye. Image: WavebreakMediaMicro.

Be on lookout for dry eye, sleep disturbance link, optometrists urged

by Staff Writer
March 5, 2026

Optometrists are being encouraged to talk to dry eye patients about their sleep patterns after research established a link between...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited